Marijuana Testing Market 2024 – Market Size & Segments Analysis, Industry Trends, Manufacturers Analysis, Opportunities and Forecast 2030

The global market value of the marijuana testing market was valued at USD 2.4 billion in 2022, and a CAGR of 16.7% is expected during the forecast period. Rising disposable income and rising acceptance of medical cannabis/marijuana are driving the demand for marijuana testing in the market. Many government and medical agencies have now accepted the benefits of certain cannabinoids like CBD for patients suffering from chronic diseases like cancer, chronic pain, arthritis, and mental health issues. Few of the countries like South Korea, Germany, Italy, and Mexico that had historically banned marijuana are now pursuing a medical cannabis program.

The heightened requirement of marijuana testing for medical purposes is the factor driving growth in the market. Technological advancements in marijuana testing all over the world are significantly driving market growth. Lack of funding and investments in testing labs and issues in transportation of cannabis samples are hindering the growth in the market significantly.

Growth Drivers

As more regions legalize marijuana, particularly for medical and recreational use, there is an increasing demand for regulatory oversight. This drives the need for accurate testing to ensure product safety, consistency, and compliance with health standards. Governments and regulatory bodies mandate stringent testing for contamination, such as pesticides, heavy metals, and residual solvents. These regulations aim to protect consumers from potential health risks. Making lab testing an essential part of supply chain.

Consumers are increasingly informed about the quality and safety of the products consumed. The development of new cannabis-based products, such as edibles, concentrates, and topicals, requires rigorous testing protocols to ensure product safety and consistency. Innovation in products necessitates the advancement in testing technologies and processing’s. Chromatography, spectrometry, and genetic testing have made marijuana testing more accurate and efficient. Advances in technology reduce turnaround time and increase lab efficiency.

The sector is attracting investors from established pharmaceuticals and healthcare companies. Private equity firms, boosting research and development and accelerating the growth of testing infrastructure. With the growing cannabis industry, the global market for marijuana testing is also expanding. Countries establishing new marijuana markets often adopt similar testing standards.

Segmentation

Service Type

·         Potency Testing

·         Residual Solvent Testing

·         Mycotoxin Testing

·         Microbial Testing’

·         Genetic Testing

·         Heavy Metal Testing

·         Pesticides Screening

·         Others

End-User

·         Cannabis Drug Manufacturers

·         Cannabis Growers

·         Research Institutes and Labs

·         Others

Regional Outlook

·         Asia Pacific

·         North America

·         Latin America

·         Europe

·         Middle East and Africa

Marijuana Testing Market by Service Type Segmentation

On the basis of service type segmentation, the marijuana testing market is segmented into potency testing, residual solvent testing, mycotoxin testing, microbial testing, genetic testing, heavy metal testing, pesticide screening, and others. Potency testing is the leading segment in the marijuana testing market and is expected to dominate the market during the forecast period. Potency testing is essential for determining the levels of active cannabinoids, primarily THC and CBD, which are the main components consumers and regulatory focus on.

Accurate labeling of these levels is essential, especially in medical marijuana products, where dosage consistency is vital. Producers need to ensure that their products consistently meet potency claims, making potency testing a core part of quality control processes. Regulatory bodies across different regions require precise potency testing to ensure products fall within the legal THC limits and meet safety standards. The rise of diverse cannabis-based products, such as edibles, oils, and capsules, requires extensive potency testing.

Regional Outlook

On the basis of the regions, the marijuana testing market is segmented into 5 regions: Asia Pacific, North America, the Middle East and Africa, Europe, and Latin America. North America is the leading segment in the market and is expected to drive growth during the forecast period due to widespread legalization all around the world. Canada has allowed recreational use of it, while many states in the United States have legalized marijuana for medical or recreational purposes. North America has established comprehensive regulatory guidelines to ensure marijuana products meet strict safety and quality standards. This regulatory infrastructure has led to higher adoption rates for testing services across both Canada and the United States of America.

North America, particularly the United States of America, has a strong research and development eco-system and technology-driven approach to cannabis testing. Major advancements in testing technologies and the presence of specialized companies with expertise in techniques like chromatography, spectrograph, and others. Chromatography, spectrometry, and genetic testing have made marijuana testing more accurate and efficient. Advances in technology reduce turnaround time and increase lab efficiency. Increasing awareness among North American consumers about the product quality and safety standards is driving growth in the marijuana testing market significantly. Rising disposable income in the region is the key cause behind the significant growth in the market.

Asia Pacific Region, including countries like Thailand and Australia, have legalized the use of marijuana for medical purposes, and there has been an increase in population in the region in emerging economies like China and India. Increasing investment by many companies in the region in marijuana testing. Technological advancements in the region and growth in the techniques like chromatography and spectrography are driving the growth in the market significantly. The sector is attracting investors from established pharmaceuticals and healthcare companies. Private equity firms, boosting research and development and accelerating the growth of testing infrastructure.

Europe is another big region in the marijuana testing due to the legalization of marijuana for medical purposes. Germany, Italy, and the Netherlands have legalized marijuana for medical purposes. European consumers are highly concerned about product quality and safety, especially in markets like Germany and the U.K. This awareness drives demand for testing that ensures accurate labeling, reliable potency levels, and freedom from contamination. Increasing investment by European companies in research and development to explore new canabbis-based medical applications such as treatments for chronic pain and epilepsy. Europe is a major market for canabbis imports, with countries like Canada and Israel exporting medical-grade cannabis to the regions. Innovations in testing technologies, including chromatography, mass spectrometry, and genetic testing, are enhancing the accuracy and efficiency of marijuana testing in Europe.

Key Players

·         Danaher Corporation

·         Agilent Technologies Inc.

·         Steep Halent Laboratory

·         LLC Sartorious AG

·         Accelerated Technologies Lalo

·         Shimazfu Scientific Instruments

·         Digipath Inc.

·         LLC

·         Eurofins Sc

·         Other Players